Maintaining momentum on immunisation in Australia
Masha Somi A and Brendan Murphy B
+ Author Affiliations
- Author Affiliations
A Australian Government Department of Health
Level 5, Scarborough House
Woden, ACT 2605, Australia
Tel: +61 2 6289 7705
Email: masha.somi@health.gov.au
B Australian Government Department of Health
GPO Box 9848
Canberra, ACT 2601, Australia
Email: brendan.murphy@health.gov.au
Microbiology Australia 38(4) 159-161 https://doi.org/10.1071/MA17057
Published: 9 November 2017
Abstract
The introduction of the National Immunisation Program 20 years ago was a catalyst for immunisation in Australia, resulting in significant improvements in immunisation coverage rates, reduced morbidity from diseases covered through the Program, and high community acceptance and support. At the same time, concerns about vaccine safety have grown, a paradoxical result of the success of vaccination and driven by a small cohort with strong anti-vaccination views. Vaccination is one of public health's greatest successes – while it's important to celebrate its success, we must also not become complacent. There is more work to be done, particularly to ensure those most at risk are also able to enjoy the benefits of immunisation.
References
[1] National Centre for Immunisation Research and Surveillance. (2015) Significant events in immunisation policy and practice in Australia. http://www.ncirs.edu.au/assets/Uploads/Immunisation-Policy-and-Practice-June-2016.pdf (accessed 26 August 2017).[2] Department of Health. (2016) AIR – annual coverage historical data. http://www.immunise.health.gov.au/internet/immunise/publishing.nsf/Content/acir-ann-cov-hist-data.htm (accessed 26 August 2017).
[3] Department of Health. (2016) AIR – annual coverage historical data – Aboriginal and Torres Strait Islander children. http://www.immunise.health.gov.au/internet/immunise/publishing.nsf/Content/acir-ann-hist-data-ATSI-child.htm (accessed 26 August 2017).
[4] Department of Health. (2016) National Immunisation Program Schedule. http://www.immunise.health.gov.au/internet/immunise/publishing.nsf/Content/nips (accessed 26 August 2017).
[5] National Centre for Immunisation Research and Surveillance. (2016) Summary of national surveillance data on vaccine preventable diseases in Australia, 2008–2011.
[6] Martin, N.V. et al. (2016) Rise in invasive serogroup W meningococcal disease in Australia, 2013-15. CDI 40, E454–E459.
[7] Reyes, J.F. et al. (2017) Beyond expectations: post-implementation data shows rotavirus vaccination is likely cost-saving in Australia. Vaccine 35, 345–352.
| Beyond expectations: post-implementation data shows rotavirus vaccination is likely cost-saving in Australia.Crossref | GoogleScholarGoogle Scholar | 1:STN:280:DC%2BC2sjjtlCksg%3D%3D&md5=ca60d6faacee8c716a05804894a9914bCAS |
[8] Leask, J. (2012) Communicating with parents about vaccination: a framework for health professionals. BMC Pediatr. 12, 154.
| Communicating with parents about vaccination: a framework for health professionals.Crossref | GoogleScholarGoogle Scholar |
[9] The Royal Children’s Hospital Melbourne. (2017) Vaccination: perspectives of Australian parents. https://www.childhealthpoll.org.au/polls/vaccination-perspectives-of-australian-parents/ (accessed 26 August 2017).
[10] Leask, J. (2017) Australians’ attitudes to vaccination are more complex than a simple ‘pro’ or ‘anti’ label. The Conversation, 9 March 2017.
[11] King, C. and Leask, J. (2017) The impact of a vaccine scare on parental views, trust and information needs: a qualitative study in Sydney, Australia. BMC Public Health 17, 106.
| The impact of a vaccine scare on parental views, trust and information needs: a qualitative study in Sydney, Australia.Crossref | GoogleScholarGoogle Scholar |
[12] Department of Health. (2013) Myths and realities: responding to arguments against vaccination.
[13] National Centre for Immunisation Research and Surveillance. (2016) Reports on adverse events following immunisation annually in communicable diseases intelligence. http://www.health.gov.au/internet/main/publishing.nsf/Content/cda-aefi-anrep.htm
[14] National Centre for Immunisation Research and Surveillance. (2017) AusVaxSafety. http://www.ncirs.edu.au/vaccine-safety/ausvaxsafety/ (accessed 27 August 2017).
[15] AIHW. (2017) Healthy communities: immunisation rates for children, 2015–16.
[16] NNDSS Annual Report Working Group (2016) Australia’s notifiable disease status, 2014: annual report of the national notifiable diseases surveillance system. CDI 40, E48–E145.
[17] AIHW. (2016) Australian burden of disease study 2011.
[18] Song, J.H. (2013) Advances in pneumococcal antibiotic resistance Expert Rev. Respir. Med. 7, 491–498.
| Advances in pneumococcal antibiotic resistanceCrossref | GoogleScholarGoogle Scholar | 1:CAS:528:DC%2BC3sXhs1eksLzK&md5=579864bf99ce521b8af851190cc7454bCAS |
[19] Sheridan, S.L. et al. (2012) Number and order of whole cell pertussis vaccines in infancy and disease protection. JAMA 308, 454–456.
| Number and order of whole cell pertussis vaccines in infancy and disease protection.Crossref | GoogleScholarGoogle Scholar | 1:CAS:528:DC%2BC38XhtlWkt7%2FF&md5=aed94faab8d0c7360df596f526d5e68bCAS |
[20] Centers for Disease Control and Prevention. (2017) Seasonal influenza vaccine effectiveness, 2005–2017. https://www.cdc.gov/flu/professionals/vaccination/effectiveness-studies.htm (accessed 27 August 2017).
[21] Sullivan, S.G. et al. (2016) Pooled influenza vaccine effectiveness estimates for Australia, 2012–2014. Epidemiol. Infect. 144, 2317–2328.
| Pooled influenza vaccine effectiveness estimates for Australia, 2012–2014.Crossref | GoogleScholarGoogle Scholar | 1:STN:280:DC%2BC28bktlChsA%3D%3D&md5=8893363ca857c52d2e6759a8215a50f5CAS |
[22] Kelly, H. et al. (2016) Influenza vaccine effectiveness in general practice and in hospital patients in Victoria, 2011–2013. Med. J. Australia 204, 76.
| Influenza vaccine effectiveness in general practice and in hospital patients in Victoria, 2011–2013.Crossref | GoogleScholarGoogle Scholar |
[23] Pharmaceutical Benefits Advisory Committee. (2015) Subsequent decisions not to recommend. http://www.pbs.gov.au/industry/listing/elements/pbac-meetings/pbac-outcomes/2015-07/web-outcomes-july-2015-subsequent-decision-not-to-recommend.pdf (accessed 27 August 2017).
[24] Menzies, R.I. et al. (2017) Vaccine myopia: adult vaccination also needs attention. Med. J. Aust. 206, 238–239.
| Vaccine myopia: adult vaccination also needs attention.Crossref | GoogleScholarGoogle Scholar |
